The simulated populations varied from general populations, to high‐risk groups (such as BRCA2 gene mutation carriers or kindreds of familial pancreatic cancer patients [FPC] or individuals with pancreatic cystic lesions), to PC patients. The gene discussed is BRCA2; the disease is familial pancreatic carcinoma.